若您需要咨询产品或有任何技术问题,请通过官方电话 400 885 9050 或邮箱 info.cn@stemcell.com 与我们联系

无动物成分的细胞解离试剂盒

人干细胞和祖细胞解离试剂盒

产品号 #(选择产品)

产品号 #05426_C

人干细胞和祖细胞解离试剂盒

产品优势

  • 针对人干细胞和祖细胞的分离和传代进行了优化
  • 即用型、无动物成分,可进行更干净的细胞培养

产品组分包括

  • ACF酶解液,250 mL
  • ACF酶抑制剂,250 mL

总览

使用无动物成分的解离试剂盒解离和传代人干细胞和祖细胞。该试剂盒与各种培养基培养的细胞兼容,并含有ACF酶解溶液和ACF酶抑制剂在内的即用型溶液。

该试剂盒原名为MesenCult™-ACF解离试剂盒,现已更名以更好地适用于其他细胞类型(如内皮细胞、HUVECs、间充质细胞、PSC衍生细胞、间充质干细胞和祖细胞、肌源干细胞和祖细胞)。

亚型
酶法相关(或酶解类产品
 
细胞类型
内皮细胞,内皮集落形成细胞(ECFCs),HUVEC细胞(人脐静脉内皮细胞),间充质细胞,PSC衍生,间充质干/祖细胞,肌源干/祖细胞
 
种属

 
应用
细胞培养
 
品牌
MesenCult
 
研究领域
内皮细胞研究,干细胞生物学
 

产品说明书及文档

请在《产品说明书》中查找相关支持信息和使用说明,或浏览下方更多实验方案。

Document Type
Product Name
Catalog #
Lot #
Language
Catalog #
05426
Lot #
All
Language
English
Document Type
Safety Data Sheet 1
Catalog #
05426
Lot #
All
Language
English
Document Type
Safety Data Sheet 2
Catalog #
05426
Lot #
All
Language
English

相关材料与文献

技术资料 (8)

文献 (2)

Focal adhesion protein abnormalities in myelodysplastic mesenchymal stromal cells. Aanei CM et al. Experimental cell research 2011 NOV

Abstract

Direct cell-cell contact between haematopoietic progenitor cells (HPCs) and their cellular microenvironment is essential to maintain 'stemness'. In cancer biology, focal adhesion (FA) proteins are involved in survival signal transduction in a wide variety of human tumours. To define the role of FA proteins in the haematopoietic microenvironment of myelodysplastic syndromes (MDS), CD73-positive mesenchymal stromal cells (MSCs) were immunostained for paxillin, pFAK [Y(397)], and HSP90α/β and p130CAS, and analysed for reactivity, intensity and cellular localisation. Immunofluorescence microscopy allowed us to identify qualitative and quantitative differences, and subcellular localisation analysis revealed that in pathological MSCs, paxillin, pFAK [Y(397)], and HSP90α/β formed nuclear molecular complexes. Increased expression of paxillin, pFAK [Y(397)], and HSP90α/β and enhanced nuclear co-localisation of these proteins correlated with a consistent proliferative advantage in MSCs from patients with refractory anaemia with excess blasts (RAEB) and negatively impacted clonogenicity of HPCs. These results suggest that signalling via FA proteins could be implicated in HPC-MSC interactions. Further, because FAK is an HSP90α/β client protein, these results suggest the utility of HSP90α/β inhibition as a target for adjuvant therapy for myelodysplasia.
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Dominici M et al. Cytotherapy 2006 JAN

Abstract

The considerable therapeutic potential of human multipotent mesenchymal stromal cells (MSC) has generated markedly increasing interest in a wide variety of biomedical disciplines. However, investigators report studies of MSC using different methods of isolation and expansion, and different approaches to characterizing the cells. Thus it is increasingly difficult to compare and contrast study outcomes, which hinders progress in the field. To begin to address this issue, the Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy proposes minimal criteria to define human MSC. First, MSC must be plastic-adherent when maintained in standard culture conditions. Second, MSC must express CD105, CD73 and CD90, and lack expression of CD45, CD34, CD14 or CD11b, CD79alpha or CD19 and HLA-DR surface molecules. Third, MSC must differentiate to osteoblasts, adipocytes and chondroblasts in vitro. While these criteria will probably require modification as new knowledge unfolds, we believe this minimal set of standard criteria will foster a more uniform characterization of MSC and facilitate the exchange of data among investigators.

更多信息

更多信息
种属 Human
质量保证:

产品仅供研究使用,不用于针对人或动物的诊断或治疗。
Copyright © 2025 by STEMCELL Technologies. All rights reserved.